Abstract 5383: Design, optimization, and validation of multiplex immunofluorescence assay for detecting biomarker expression on circulating tumor cells in breast cancer
Tanya Kumar(University of Houston), Meghana V. Trivedi(University of Houston), Hariprasad Thangavel(Hackensack Meridian Health), Raksha R. Bhat(University of Houston), Noor Mazin Abdulkareem(The University of Texas MD Anderson Cancer Center), Lacey E. Dobrolecki(Baylor College of Medicine), Michael T. Lewis(Baylor College of Medicine)
Cited by 0
Related Papers
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
|Nature|2017|853
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
|Cancer Research|2013|485
Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer
|Cell Reports|2016|320
Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer
|Clinical Cancer Research|2013|273